| 前收市價 | 11.70 |
| 開市 | 7.33 |
| 買盤 | 6.60 |
| 賣出價 | 8.40 |
| 拍板 | 540.00 |
| 到期日 | 2024-11-15 |
| 今日波幅 | 7.33 - 7.33 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 279 |
ZacksMcKesson (MCK) Reaches 52-Week High: What's Aiding the Stock?
Investors are optimistic about McKesson's (MCK) strength in its Biologics business.
ZacksMcKesson (MCK) Increases Despite Market Slip: Here's What You Need to Know
In the most recent trading session, McKesson (MCK) closed at $603.24, indicating a +0.05% shift from the previous trading day.
- Zacks
McKesson (MCK) Introduces FDA-Approved Prostate Cancer Drug
The availability of the FDA-approved drug via McKesson's (MCK) independent specialty pharmacy is expected to give patients improved treatment options for prostate cancer.
